366 related articles for article (PubMed ID: 22581564)
1. Use of abatacept in rheumatoid arthritis.
von Kempis J; Dudler J; Hasler P; Kyburz D; Tyndall A; Zufferey P; Villiger PM
Swiss Med Wkly; 2012; 142():w13581. PubMed ID: 22581564
[TBL] [Abstract][Full Text] [Related]
2. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
[TBL] [Abstract][Full Text] [Related]
3. Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes.
Bathon J; Robles M; Ximenes AC; Nayiager S; Wollenhaupt J; Durez P; Gomez-Reino J; Grassi W; Haraoui B; Shergy W; Park SH; Genant H; Peterfy C; Becker JC; Covucci A; Moniz Reed D; Helfrick R; Westhovens R
Ann Rheum Dis; 2011 Nov; 70(11):1949-56. PubMed ID: 21821865
[TBL] [Abstract][Full Text] [Related]
4. Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
Sherrer Y
Curr Med Res Opin; 2008 Aug; 24(8):2283-94. PubMed ID: 18590608
[TBL] [Abstract][Full Text] [Related]
5. Safety profile of abatacept in rheumatoid arthritis: a review.
Khraishi M; Russell A; Olszynski WP
Clin Ther; 2010 Oct; 32(11):1855-70. PubMed ID: 21095481
[TBL] [Abstract][Full Text] [Related]
6. Modulation of T-cell co-stimulation in rheumatoid arthritis: clinical experience with abatacept.
Laganà B; Vinciguerra M; D'Amelio R
Clin Drug Investig; 2009; 29(3):185-202. PubMed ID: 19243211
[TBL] [Abstract][Full Text] [Related]
7. Greater remission rates in patients with early versus long-standing disease in biologic-naive rheumatoid arthritis patients treated with abatacept: a post hoc analysis of randomized clinical trial data.
Yazici Y; Moniz Reed D; Klem C; Rosenblatt L; Wu G; Kremer JM
Clin Exp Rheumatol; 2011; 29(3):494-9. PubMed ID: 21722499
[TBL] [Abstract][Full Text] [Related]
8. Abatacept: A Review in Rheumatoid Arthritis.
Blair HA; Deeks ED
Drugs; 2017 Jul; 77(11):1221-1233. PubMed ID: 28608166
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety of abatacept in patients with rheumatoid arthritis.
Atzeni F; Sarzi-Puttini P; Mutti A; Bugatti S; Cavagna L; Caporali R
Autoimmun Rev; 2013 Oct; 12(12):1115-7. PubMed ID: 23800448
[TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Abatacept for people with active rheumatoid arthritis.
Ann Intern Med; 2006 Jun; 144(12):I18. PubMed ID: 16785473
[No Abstract] [Full Text] [Related]
11. Abatacept: a novel treatment for rheumatoid arthritis.
Lundquist LM
Expert Opin Pharmacother; 2007 Oct; 8(14):2371-9. PubMed ID: 17927490
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors.
Westhovens R; Robles M; Ximenes AC; Nayiager S; Wollenhaupt J; Durez P; Gomez-Reino J; Grassi W; Haraoui B; Shergy W; Park SH; Genant H; Peterfy C; Becker JC; Covucci A; Helfrick R; Bathon J
Ann Rheum Dis; 2009 Dec; 68(12):1870-7. PubMed ID: 19124524
[TBL] [Abstract][Full Text] [Related]
13. Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.
Kremer JM; Genant HK; Moreland LW; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Li T; Ge Z; Becker JC; Westhovens R
Ann Intern Med; 2006 Jun; 144(12):865-76. PubMed ID: 16785475
[TBL] [Abstract][Full Text] [Related]
14. Abatacept in the treatment of rheumatoid arthritis.
Todd DJ; Costenbader KH; Weinblatt ME
Int J Clin Pract; 2007 Mar; 61(3):494-500. PubMed ID: 17313619
[TBL] [Abstract][Full Text] [Related]
15. [A novel treatment option in rheumatoid arthritis: abatacept, a selective modulator of T-cell co-stimulation].
Dejaco C; Duftner C; Wipfler E; Schirmer M
Wien Med Wochenschr; 2009; 159(3-4):70-5. PubMed ID: 19247593
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of abatacept in routine care of patients with rheumatoid arthritis: Orencia(®) as Biological Intensive Treatment for RA (ORBIT) study.
Tanaka Y; Kubo S; Yamanaka H; Amano K; Hirata S; Tanaka E; Nagasawa H; Yasuoka H; Takeuchi T
Mod Rheumatol; 2014 Sep; 24(5):754-62. PubMed ID: 25036232
[TBL] [Abstract][Full Text] [Related]
17. A nursing guide to infusion therapy with abatacept for the treatment of rheumatoid arthritis.
Barr C
J Infus Nurs; 2007; 30(2):96-104; quiz 120. PubMed ID: 17413494
[TBL] [Abstract][Full Text] [Related]
18. Comparative overview of safety of the biologics in rheumatoid arthritis.
Khraishi M
J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists.
Isaacs JD
Expert Opin Biol Ther; 2009 Dec; 9(12):1463-75. PubMed ID: 19916731
[TBL] [Abstract][Full Text] [Related]
20. Abatacept: a review of its use in the management of rheumatoid arthritis.
Keating GM
Drugs; 2013 Jul; 73(10):1095-119. PubMed ID: 23794171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]